Caris Life Sciences, Inc. (CAI)
27.43
+1.30
(+4.98%)
USD |
NASDAQ |
Aug 25, 12:34
Caris Life Sciences Market Cap : 7.751B for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 7.384B |
| August 21, 2026 | 7.423B |
| August 20, 2026 | 6.946B |
| August 19, 2026 | 6.432B |
| August 18, 2026 | 5.926B |
| August 17, 2026 | 6.112B |
| August 14, 2026 | 6.160B |
| August 13, 2026 | 6.268B |
| August 12, 2026 | 6.290B |
| August 11, 2026 | 6.539B |
| August 10, 2026 | 6.612B |
| August 07, 2026 | 6.426B |
| August 06, 2026 | 5.652B |
| August 05, 2026 | 4.648B |
| August 04, 2026 | 4.550B |
| August 03, 2026 | 4.612B |
| July 31, 2026 | 4.429B |
| July 30, 2026 | 4.548B |
| July 29, 2026 | 4.407B |
| July 28, 2026 | 4.407B |
| July 27, 2026 | 4.418B |
| July 24, 2026 | 4.387B |
| July 23, 2026 | 4.423B |
| July 22, 2026 | 4.347B |
| July 21, 2026 | 4.446B |
| Date | Value |
|---|---|
| July 20, 2026 | 4.398B |
| July 17, 2026 | 4.661B |
| July 16, 2026 | 4.658B |
| July 15, 2026 | 4.935B |
| July 14, 2026 | 4.791B |
| July 13, 2026 | 4.822B |
| July 10, 2026 | 4.802B |
| July 09, 2026 | 5.051B |
| July 08, 2026 | 4.896B |
| July 07, 2026 | 4.938B |
| July 06, 2026 | 5.034B |
| July 02, 2026 | 5.173B |
| July 01, 2026 | 5.300B |
| June 30, 2026 | 5.037B |
| June 29, 2026 | 5.178B |
| June 26, 2026 | 5.229B |
| June 25, 2026 | 5.286B |
| June 24, 2026 | 5.130B |
| June 23, 2026 | 4.975B |
| June 22, 2026 | 4.893B |
| June 18, 2026 | 5.221B |
| June 17, 2026 | 5.048B |
| June 16, 2026 | 5.082B |
| June 15, 2026 | 5.139B |
| June 12, 2026 | 5.079B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CareDx, Inc. | 2.572B |
| Myriad Genetics, Inc. | 295.40M |
| BioRestorative Therapies, Inc. | 5.605M |
| Natera, Inc. | 47.77B |
| Exagen, Inc. | 184.96M |
Market Cap Related Metrics
| PE Ratio | 73.68 |
| PS Ratio | 7.831 |
| Price to Book Value | 13.10 |
| Price to Free Cash Flow | 66.66 |
| Price | 27.43 |
| Earnings Yield | 1.36% |
| Operating PE Ratio | 50.56 |
| Normalized PE Ratio | 61.68 |